Category Archives: Uncategorized

27 Sep

CALL FOR PROPOSALS FOR ACTION GRANTS UNDER 2018 RIGHTS, EQUALITY AND CITIZENSHIP WORK PROGRAMME

[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: REC-AG-2018Pillar: REC Programme 2014-2020Opening Date: Deadline: Thu, 31 May 2018 17:00:00 (Brussels local time)Modification Date: Wed, 26

26 Sep

When should I start applying to biotech/pharma jobs (current senior in college)?

I’m majoring in Chemical Engineering and when I graduate, I’m looking for a Process Development type job at a biotech

26 Sep

Big Pharma Seeks More Partnerships, Evidence in Digital Therapeutics

“Digital therapeutics” startups are starting to win more respect-and investment dollars-from pharmaceutical giants. But the two sides are still figuring

26 Sep

#JohnnyAppleseedDay | How Biotech Is Keeping Apples Fresh and Cutting Down on Food Waste

Each year on September 26, just days after the start of autumn, we celebrate Johnny Appleseed Day. And while this

26 Sep

Research Headlines – Predicting Atlantic Ocean and climate changes… new insights

[Source: Research & Innovation] European researchers joined forces with Atlantic African counterparts to explore the impacts of ocean changes on

25 Sep

Former Alnylam Exec Jared Gollob Named Kymera Chief Medical Officer

Jared Gollob has been appointed chief medical officer of Cambridge, MA-based Kymera Therapeutics. Gollob most recently worked at Alynylam Pharmaceuticals

25 Sep

Inducement prize: Online security – Seamless personal authentication

[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: H2020-OnlineSecurityPrize-2017Pillar: Industrial LeadershipOpening Date: Deadline: Thu, 27 Sep 2018 17:00:00 (Brussels local time)Modification Date: Tue, 25 Sep

25 Sep

Harnessing the Power of Ag Microbials

Editor’s Note: As part of BIO’s 25th Anniversary celebration we will be spotlighting biotechnology innovations that have made a major impact over the

25 Sep

Former Kite Pharma Exec Anthony Polverino Named Zymeworks CSO

Anthony Polverino has been appointed executive vice president of early development and chief scientific officer of Vancouver, BC-based Zymeworks (NYSE: